Clínica Baviera, S.A. (BME:CBAV)
35.70
+0.10 (0.28%)
Apr 2, 2025, 5:35 PM CET
Clínica Baviera Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Market Capitalization | 571 | 499 | 375 | 284 | 346 | 230 | Upgrade
|
Market Cap Growth | 33.02% | 33.02% | 31.81% | -17.69% | 50.35% | -1.40% | Upgrade
|
Enterprise Value | 593 | 529 | 376 | 286 | 360 | 264 | Upgrade
|
Last Close Price | 35.70 | 31.20 | 22.08 | 16.18 | 18.92 | 11.96 | Upgrade
|
PE Ratio | 14.45 | 12.41 | 10.42 | 9.64 | 12.62 | 16.49 | Upgrade
|
Forward PE | - | 23.87 | 23.87 | 23.87 | 23.87 | 23.87 | Upgrade
|
PS Ratio | 2.19 | 1.88 | 1.65 | 1.43 | 2.00 | 1.88 | Upgrade
|
PB Ratio | 5.89 | 5.07 | 4.06 | 4.16 | 6.24 | 5.12 | Upgrade
|
P/TBV Ratio | 8.33 | 8.33 | 5.09 | 5.44 | 8.86 | 7.84 | Upgrade
|
P/FCF Ratio | 15.75 | 13.76 | 10.67 | 7.23 | 9.53 | 9.73 | Upgrade
|
P/OCF Ratio | 7.95 | 7.95 | 6.49 | 5.33 | 7.38 | 7.31 | Upgrade
|
PEG Ratio | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | 0.78 | Upgrade
|
EV/Sales Ratio | 2.23 | 1.99 | 1.66 | 1.44 | 2.08 | 2.15 | Upgrade
|
EV/EBITDA Ratio | 7.74 | 6.92 | 5.66 | 5.04 | 6.75 | 7.96 | Upgrade
|
EV/EBIT Ratio | 10.65 | 9.51 | 7.52 | 6.82 | 9.13 | 13.33 | Upgrade
|
EV/FCF Ratio | 16.34 | 14.60 | 10.71 | 7.27 | 9.93 | 11.18 | Upgrade
|
Debt / Equity Ratio | 0.60 | 0.60 | 0.51 | 0.70 | 0.93 | 1.22 | Upgrade
|
Debt / EBITDA Ratio | 0.77 | 0.77 | 0.71 | 0.84 | 0.96 | 1.65 | Upgrade
|
Debt / FCF Ratio | 1.62 | 1.62 | 1.35 | 1.21 | 1.42 | 2.31 | Upgrade
|
Asset Turnover | 1.36 | 1.36 | 1.38 | 1.40 | 1.36 | 1.10 | Upgrade
|
Inventory Turnover | 46.27 | 46.27 | 49.67 | 47.16 | 47.03 | 45.24 | Upgrade
|
Quick Ratio | 0.86 | 0.86 | 1.18 | 1.01 | 1.00 | 0.91 | Upgrade
|
Current Ratio | 0.95 | 0.95 | 1.28 | 1.09 | 1.06 | 0.97 | Upgrade
|
Return on Equity (ROE) | 43.16% | 43.16% | 45.73% | 48.72% | 55.70% | 37.33% | Upgrade
|
Return on Assets (ROA) | 17.81% | 17.81% | 19.03% | 18.47% | 19.36% | 11.14% | Upgrade
|
Return on Capital (ROIC) | 23.45% | 23.45% | 24.46% | 23.53% | 23.90% | 13.48% | Upgrade
|
Return on Capital Employed (ROCE) | 34.50% | 34.50% | 37.50% | 38.50% | 40.30% | 22.40% | Upgrade
|
Earnings Yield | 7.04% | 8.06% | 9.59% | 10.38% | 7.92% | 6.07% | Upgrade
|
FCF Yield | 6.35% | 7.27% | 9.37% | 13.83% | 10.50% | 10.28% | Upgrade
|
Dividend Yield | 4.41% | - | 7.11% | 8.04% | 5.44% | 4.61% | Upgrade
|
Payout Ratio | 64.39% | 64.39% | 36.26% | 56.89% | 62.62% | - | Upgrade
|
Buyback Yield / Dilution | 0.15% | 0.15% | 0.00% | - | -0.01% | 0.01% | Upgrade
|
Total Shareholder Return | 4.57% | 0.15% | 7.11% | 8.04% | 5.43% | 4.62% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.